KLRA Stock: Price, Earnings History and SEC Filings
Kailera Therapeutics, Inc. (KLRA) last traded at $12.86, down 4.10% on the latest session and up 12.6% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-1.09 against an analyst estimate of $-0.74, a miss of 47.3%.
$12.86 -4.10%
1 month+12.61%
52-week high$28.23
52-week low$9.76
Volume868,428
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
KLRA earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 12, 2026 | $-1.09 | $-0.74 | -47.30% |
KLRA beat the analyst EPS estimate in 0 of its last 1 reported quarters. Source: Nasdaq.
Latest SEC filings for KLRA
SEC filing data is not available right now. You can search for KLRA on SEC EDGAR.
KLRA news
- Inhibikase Therapeutics Appoints Scott Wasserman to Board of DirectorsOct 20, 2026 · finance.yahoo.com
About Kailera Therapeutics, Inc.
Kailera Therapeutics, Inc. (KLRA) is a US-listed public company on Nasdaq.